These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37898709)

  • 1. Amyloidogenic 60-71 deletion/ValThr insertion mutation of apolipoprotein A-I generates a new aggregation-prone segment that promotes nucleation through entropic effects.
    Namba N; Ohgita T; Tamagaki-Asahina H; Nishitsuji K; Shimanouchi T; Sato T; Saito H
    Sci Rep; 2023 Oct; 13(1):18514. PubMed ID: 37898709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I.
    Mizuguchi C; Nakagawa M; Namba N; Sakai M; Kurimitsu N; Suzuki A; Fujita K; Horiuchi S; Baba T; Ohgita T; Nishitsuji K; Saito H
    J Biol Chem; 2019 Sep; 294(36):13515-13524. PubMed ID: 31341020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual role of an N-terminal amyloidogenic mutation in apolipoprotein A-I: destabilization of helix bundle and enhancement of fibril formation.
    Adachi E; Nakajima H; Mizuguchi C; Dhanasekaran P; Kawashima H; Nagao K; Akaji K; Lund-Katz S; Phillips MC; Saito H
    J Biol Chem; 2013 Jan; 288(4):2848-56. PubMed ID: 23233678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin promotes fibril formation by the N-terminal fragment of amyloidogenic apolipoprotein A-I.
    Mikawa S; Mizuguchi C; Nishitsuji K; Baba T; Shigenaga A; Shimanouchi T; Sakashita N; Otaka A; Akaji K; Saito H
    FEBS Lett; 2016 Oct; 590(20):3492-3500. PubMed ID: 27654470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes.
    Mizuguchi C; Ogata F; Mikawa S; Tsuji K; Baba T; Shigenaga A; Shimanouchi T; Okuhira K; Otaka A; Saito H
    J Biol Chem; 2015 Aug; 290(34):20947-20959. PubMed ID: 26175149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Phosphatidylserine and Cholesterol on Membrane-mediated Fibril Formation by the N-terminal Amyloidogenic Fragment of Apolipoprotein A-I.
    Mizuguchi C; Nakamura M; Kurimitsu N; Ohgita T; Nishitsuji K; Baba T; Shigenaga A; Shimanouchi T; Okuhira K; Otaka A; Saito H
    Sci Rep; 2018 Apr; 8(1):5497. PubMed ID: 29615818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the known pathogenic mutations on the aggregation pathway of the amyloidogenic peptide of apolipoprotein A-I.
    Raimondi S; Guglielmi F; Giorgetti S; Di Gaetano S; Arciello A; Monti DM; Relini A; Nichino D; Doglia SM; Natalello A; Pucci P; Mangione P; Obici L; Merlini G; Stoppini M; Robustelli P; Tartaglia GG; Vendruscolo M; Dobson CM; Piccoli R; Bellotti V
    J Mol Biol; 2011 Apr; 407(3):465-76. PubMed ID: 21296086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylethanolamine accelerates aggregation of the amyloidogenic N-terminal fragment of apoA-I.
    Kurimitsu N; Mizuguchi C; Fujita K; Taguchi S; Ohgita T; Nishitsuji K; Shimanouchi T; Saito H
    FEBS Lett; 2020 May; 594(9):1443-1452. PubMed ID: 31968125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an amyloid fibril forming peptide comprising residues 46-59 of apolipoprotein A-I.
    Wong YQ; Binger KJ; Howlett GJ; Griffin MD
    FEBS Lett; 2012 Jun; 586(13):1754-8. PubMed ID: 22609356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of enhanced aggregation and fibril formation of Parkinson's disease-related variants of α-synuclein.
    Ohgita T; Namba N; Kono H; Shimanouchi T; Saito H
    Sci Rep; 2022 Apr; 12(1):6770. PubMed ID: 35474118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extreme N-terminal region of human apolipoprotein A-I has a strong propensity to form amyloid fibrils.
    Adachi E; Kosaka A; Tsuji K; Mizuguchi C; Kawashima H; Shigenaga A; Nagao K; Akaji K; Otaka A; Saito H
    FEBS Lett; 2014 Jan; 588(3):389-94. PubMed ID: 24316228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibril growth kinetics reveal a region of beta2-microglobulin important for nucleation and elongation of aggregation.
    Platt GW; Routledge KE; Homans SW; Radford SE
    J Mol Biol; 2008 Apr; 378(1):251-63. PubMed ID: 18342332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis.
    Das M; Mei X; Jayaraman S; Atkinson D; Gursky O
    FEBS J; 2014 Jun; 281(11):2525-42. PubMed ID: 24702826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the Aggregation of Apolipoprotein A-I.
    Frankel R; Sparr E; Linse S
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical mechanisms of aggregation and fibril formation of α-synuclein and apolipoprotein A-I.
    Ohgita T; Kono H; Namba N; Saito H
    Biophys Physicobiol; 2024; 21(1):e210005. PubMed ID: 38803339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational and aggregation properties of the 1-93 fragment of apolipoprotein A-I.
    Petrlova J; Bhattacherjee A; Boomsma W; Wallin S; Lagerstedt JO; Irbäck A
    Protein Sci; 2014 Nov; 23(11):1559-71. PubMed ID: 25131953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Stability and Local Dynamics in Disease-Causing Mutants of Human Apolipoprotein A-I: What Makes the Protein Amyloidogenic?
    Das M; Wilson CJ; Mei X; Wales TE; Engen JR; Gursky O
    J Mol Biol; 2016 Jan; 428(2 Pt B):449-62. PubMed ID: 26562506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipids enhance nucleation but not elongation of apolipoprotein C-II amyloid fibrils.
    Ryan TM; Teoh CL; Griffin MD; Bailey MF; Schuck P; Howlett GJ
    J Mol Biol; 2010 Jun; 399(5):731-40. PubMed ID: 20433849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The polyphenol (-)-epigallocatechin-3-gallate prevents apoA-IIowa amyloidosis in vitro and protects human embryonic kidney 293 cells against amyloid cytotoxicity.
    Nakajima H; Nishitsuji K; Kawashima H; Kuwabara K; Mikawa S; Uchimura K; Akaji K; Kashiwada Y; Kobayashi N; Saito H; Sakashita N
    Amyloid; 2016; 23(1):17-25. PubMed ID: 26701221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity amphipathic modulators of amyloid fibril nucleation and elongation.
    Ryan TM; Griffin MD; Teoh CL; Ooi J; Howlett GJ
    J Mol Biol; 2011 Feb; 406(3):416-29. PubMed ID: 21185302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.